STOCK TITAN

[SCHEDULE 13G/A] Innoviva, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Bank of Nova Scotia reported ownership of 3,585,830 shares of Innoviva, Inc. common stock, representing 5.55% of the class, on a Schedule 13G/A filing. The bank identifies itself as a parent holding company organized in Canada and states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Innoviva. The filing lists sole voting and dispositive power over the reported shares and supplies Innoviva's principal executive office address.

Bank of Nova Scotia ha dichiarato la proprietà di 3,585,830 azioni ordinarie di Innoviva, Inc., pari al 5.55% della classe, in un deposito Schedule 13G/A. La banca si identifica come società holding madre con sede in Canada e afferma che le azioni sono detenute nell'ordinaria gestione aziendale e non al fine di modificare o influenzare il controllo di Innoviva. Il deposito indica il potere esclusivo di voto e dispositive sulle azioni riportate e fornisce l'indirizzo dell'ufficio esecutivo principale di Innoviva.

Bank of Nova Scotia declaró la propiedad de 3,585,830 acciones ordinarias de Innoviva, Inc., que representan el 5.55% de la clase, en una presentación Schedule 13G/A. El banco se identifica como una sociedad matriz constituida en Canadá y afirma que las acciones se mantienen en el curso ordinario del negocio y no con el propósito de cambiar o influir en el control de Innoviva. La presentación indica el poder exclusivo de voto y dispositivo sobre las acciones informadas y proporciona la dirección de la oficina ejecutiva principal de Innoviva.

Bank of Nova Scotia는 Schedule 13G/A 제출서에서 Innoviva, Inc. 보통주 3,585,830주(해당 클래스의 5.55%에 해당)를 보유하고 있다고 보고했습니다. 은행은 캐나다에 설립된 모(母)지주회사로 자신을 밝히고 있으며, 해당 주식은 영업 과정에서 보유된 것이며 Innoviva의 지배권을 변경하거나 영향을 미칠 목적으로 보유한 것이 아니라고 명시했습니다. 제출서에는 보고된 주식에 대한 단독 의결권 및 처분권이 기재되어 있으며 Innoviva의 본사 주소를 제공합니다.

Bank of Nova Scotia a déclaré détenir 3,585,830 actions ordinaires d'Innoviva, Inc., représentant 5.55% de la catégorie, dans un dépôt Schedule 13G/A. La banque s'identifie comme une société holding mère organisée au Canada et indique que les actions sont détenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contrôle d'Innoviva. Le dépôt précise le pouvoir exclusif de vote et de disposition sur les actions déclarées et fournit l'adresse du siège social principal d'Innoviva.

Bank of Nova Scotia meldete im Schedule 13G/A-Bericht den Besitz von 3,585,830 Stammaktien von Innoviva, Inc., was 5.55% der Klasse entspricht. Die Bank gibt an, eine Mutterholding mit Sitz in Kanada zu sein, und erklärt, die Aktien im gewöhnlichen Geschäftsverkehr zu halten und nicht mit der Absicht, die Kontrolle über Innoviva zu ändern oder zu beeinflussen. Die Einreichung nennt die ausschließliche Stimm- und Verfügungsgewalt über die gemeldeten Aktien und enthält die Adresse der Hauptgeschäftsstelle von Innoviva.

Positive
  • Disclosure of a material stake: The filing transparently reports a >5% position (3,585,830 shares; 5.55%), meeting regulatory requirements.
  • Explicit non-control certification: The filer states the shares are held in the ordinary course of business and not to influence control, which reduces immediate governance concerns.
Negative
  • None.

Insights

TL;DR A large financial institution holds a disclosed passive stake just above 5%, notable but not disclosed as an activist intent.

The 5.55% stake held by Bank of Nova Scotia is material because it crosses the 5% reporting threshold, which can attract investor attention. However, the filer certifies the position is held in the ordinary course of business and not intended to influence control, suggesting a passive ownership profile. For valuation or trading impact, markets typically view such Schedule 13G filings as transparency events rather than immediate catalysts unless followed by further disclosures or actions.

TL;DR Disclosure signals a material passive stake; no governance change signaled by this filing.

The filing classifies Bank of Nova Scotia as a parent holding company and explicitly certifies non-control intent, which limits immediate governance implications. Because voting and dispositive powers are reported as sole for the entire position, the bank could influence votes if it chose to, but the certification indicates no current plan to do so. Investors and the issuer should monitor for any subsequent Schedule 13D or 13G amendments that would indicate active engagement.

Bank of Nova Scotia ha dichiarato la proprietà di 3,585,830 azioni ordinarie di Innoviva, Inc., pari al 5.55% della classe, in un deposito Schedule 13G/A. La banca si identifica come società holding madre con sede in Canada e afferma che le azioni sono detenute nell'ordinaria gestione aziendale e non al fine di modificare o influenzare il controllo di Innoviva. Il deposito indica il potere esclusivo di voto e dispositive sulle azioni riportate e fornisce l'indirizzo dell'ufficio esecutivo principale di Innoviva.

Bank of Nova Scotia declaró la propiedad de 3,585,830 acciones ordinarias de Innoviva, Inc., que representan el 5.55% de la clase, en una presentación Schedule 13G/A. El banco se identifica como una sociedad matriz constituida en Canadá y afirma que las acciones se mantienen en el curso ordinario del negocio y no con el propósito de cambiar o influir en el control de Innoviva. La presentación indica el poder exclusivo de voto y dispositivo sobre las acciones informadas y proporciona la dirección de la oficina ejecutiva principal de Innoviva.

Bank of Nova Scotia는 Schedule 13G/A 제출서에서 Innoviva, Inc. 보통주 3,585,830주(해당 클래스의 5.55%에 해당)를 보유하고 있다고 보고했습니다. 은행은 캐나다에 설립된 모(母)지주회사로 자신을 밝히고 있으며, 해당 주식은 영업 과정에서 보유된 것이며 Innoviva의 지배권을 변경하거나 영향을 미칠 목적으로 보유한 것이 아니라고 명시했습니다. 제출서에는 보고된 주식에 대한 단독 의결권 및 처분권이 기재되어 있으며 Innoviva의 본사 주소를 제공합니다.

Bank of Nova Scotia a déclaré détenir 3,585,830 actions ordinaires d'Innoviva, Inc., représentant 5.55% de la catégorie, dans un dépôt Schedule 13G/A. La banque s'identifie comme une société holding mère organisée au Canada et indique que les actions sont détenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contrôle d'Innoviva. Le dépôt précise le pouvoir exclusif de vote et de disposition sur les actions déclarées et fournit l'adresse du siège social principal d'Innoviva.

Bank of Nova Scotia meldete im Schedule 13G/A-Bericht den Besitz von 3,585,830 Stammaktien von Innoviva, Inc., was 5.55% der Klasse entspricht. Die Bank gibt an, eine Mutterholding mit Sitz in Kanada zu sein, und erklärt, die Aktien im gewöhnlichen Geschäftsverkehr zu halten und nicht mit der Absicht, die Kontrolle über Innoviva zu ändern oder zu beeinflussen. Die Einreichung nennt die ausschließliche Stimm- und Verfügungsgewalt über die gemeldeten Aktien und enthält die Adresse der Hauptgeschäftsstelle von Innoviva.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



BANK OF NOVA SCOTIA
Signature:Raj Sachdeva
Name/Title:Vice President, Head of GBM&T, Compliance Canada
Date:09/03/2025

FAQ

How many Innoviva (INVA) shares does Bank of Nova Scotia own?

The filing reports 3,585,830 shares beneficially owned.

What percentage of INVA does Bank of Nova Scotia hold?

The reported stake represents 5.55% of Innoviva's common stock class.

Is the Bank of Nova Scotia seeking to influence control of Innoviva (INVA)?

No; the filing certifies the shares are not acquired or held to change or influence control of the issuer.

What voting and dispositive powers does the filer report for INVA shares?

The filer reports sole voting power and sole dispositive power over all 3,585,830 shares, with no shared powers.

What type of reporting person filed the Schedule 13G/A for INVA?

The Schedule identifies the filer as a parent holding company organized in Canada.
Innoviva

NASDAQ:INVA

INVA Rankings

INVA Latest News

INVA Latest SEC Filings

INVA Stock Data

1.32B
62.36M
0.98%
128.46%
15.38%
Biotechnology
Pharmaceutical Preparations
Link
United States
BURLINGAME